What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?

Parasites and Vectors

Volumn 8, Issue 1, 2015, Pages

  Anderson, R M ^a,b   Turner, H C ^a,b   Farrell, S H ^a,b   Yang, Jie ^a,b   Truscott, J E ^a,b  

^a London Centre for Neglected Tropical Disease Research   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DETERMINISTIC HYBRID MODEL; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; LIFE EXPECTANCY; MASS DRUG ADMINISTRATION PROGRAM; MATHEMATICAL MODEL; NONHUMAN; PARASITE LOAD; PARASITE TRANSMISSION; PATHOGEN CLEARANCE; PRESCHOOL CHILD; PREVALENCE; REINFECTION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL CHILD; TREATMENT DURATION; VALIDATION PROCESS; DISEASE ERADICATION; DISEASE TRANSMISSION; DRUG THERAPY; ENDEMIC DISEASE; PREVENTION AND CONTROL; PROCEDURES; THEORETICAL MODEL; TIME FACTOR; WORLD HEALTH ORGANIZATION;

ANTHELMINTICS; DISEASE ERADICATION; DISEASE TRANSMISSION, INFECTIOUS; DRUG THERAPY; ENDEMIC DISEASES; HUMANS; MODELS, THEORETICAL; SCHISTOSOMIASIS; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84945180084     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-015-1157-y     Document Type: Article

References (45)

1. Country leadership and collaboration on neglected tropical diseases: third progress report of the London Declaration [http://unitingtocombatntds.org/sites/default/files/document/UTCNTD%20FULL%20REPORT.pdf]
2. Global Schistosomiasis Alliance [http://www.eliminateschisto.org/]
3. WHA resolution 54.19 Schistosomiasis and soil-transmitted helminth infections [http://www.who.int/neglected-diseases/mediacentre/WHA-54.19-Eng.pdf]
4. WHO: Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases. In. Edited by Holmes P; 2015: 191.
5. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford. New York: Oxford University Press; 1991.
6. Truscott JE, Hollingsworth TD, Brooker SJ, Anderson RM. Can chemotherapy alone eliminate the transmission of soil transmitted helminths? Parasites & Vectors. 2014;7(1):266.
7. Anderson RM, Truscott JE, Hollingsworth TD. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130435.
8. Truscott J, Hollingsworth TD, Anderson R. Modeling the interruption of the transmission of soil-transmitted helminths by repeated mass chemotherapy of school-age children. PLoS Negl Trop Dis. 2014;8(12), e3323.
9. Macdonald G. The dynamics of helminth infections, with special reference to schistosomes. Trans R Soc Trop Med Hyg. 1965;59(5):489-506.
10. Anderson RM, May RM. Herd immunity to helminth infection and implications for parasite control. Nature. 1985;315(6019):493-6.
11. May RM. Togetherness among Schistosomes: its effects on the dynamics of the infection. Math Biosci. 1977;35:301-43.
12. Cheever AW, Kamel IA, Elwi AM, Mosimann JE, Danner R. Schistosoma mansoni and S. haematobium infections in Egypt. II. Quantitative parasitological findings at necropsy. Am J Trop Med Hyg. 1977;26(4):702-16.
13. Bensted-Smith R, Anderson RM, Butterworth AE, Dalton PR, Kariuki HC, Koech D, et al. Evidence for predisposition of individual patients to reinfection with Schistosoma mansoni after treatment. Trans R Soc Trop Med Hyg. 1987;81(4):651-4.
14. Guyatt HL, Smith T, Gryseels B, Lengeler C, Mshinda H, Siziya S, et al. Aggregation in schistosomiasis: comparison of the relationships between prevalence and intensity in different endemic areas. Parasitology. 1994;109(Pt 1):45-55.
15. Anderson RM, May RM. Population dynamics of human helminth infections: control by chemotherapy. Nature. 1982;297(5867):557-63.
16. Anderson RM, May RM. Helminth infections of humans: mathematical models, population dynamics, and control. Adv Parasitol. 1985;24:1-101.
17. French MD, Churcher TS, Gambhir M, Fenwick A, Webster JP, Kabatereine NB, et al. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl Trop Dis. 2010;4(11), e897.
18. Tingley GA, Butterworth AE, Anderson RM, Kariuki HC, Koech D, Mugambi M, et al. Predisposition of humans to infection with Schistosoma mansoni: evidence from the reinfection of individuals following chemotherapy. Trans R Soc Trop Med Hyg. 1988;82(3):448-52.
19. Gurarie D, King CH. Heterogeneous model of schistosomiasis transmission and long-term control: the combined influence of spatial variation and age-dependent factors on optimal allocation of drug therapy. Parasitology. 2005;130(Pt 1):49-65.
20. Anderson RM, Medley GF. Community control of helminth infections of man by mass and selective chemotherapy. Parasitology. 1985;90:629-60.
21. Gurarie D, King CH. Population biology of Schistosoma mating, aggregation, and transmission breakpoints: more reliable model analysis for the end-game in communities at risk. PLoS One. 2014;9(12), e115875.
22. Number of children requiring PCT for STH [http://apps.who.int/neglected-diseases/ntddata/sth/sth.html]
23. WHO: Preventive Chemotheraphy in Human Helminthiasis. In. Geneva, Switzerland: World Health Organization; 2006.
24. Butterworth AE, Sturrock RF, Ouma JH, Mbugua GG, Fulford AJ, Kariuki HC, et al. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology. 1991;103(Pt 3):339-55.
25. Fulford AJ, Butterworth AE, Sturrock RF, Ouma JH. On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology. 1992;105(Pt 2):219-27.
26. Fulford AJ, Butterworth AE, Ouma JH, Sturrock RF. A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology. 1995;110(Pt 3):307-16.
27. Warren KS. Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis. 1973;127(5):595-609.
28. Siddiqui AA, Siddiqui BA, Ganley-Leal L. Schistosomiasis vaccines. Hum Vaccin. 2011;7(11):1192-7.
29. Pullan RL, Kabatereine NB, Quinnell RJ, Brooker S. Spatial and genetic epidemiology of hookworm in a rural community in Uganda. PLoS Negl Trop Dis. 2010;4(6), e713.
30. McCullough FS, Bradley DJ. Egg output stability and the epidemiology of Schistosoma haematobium. I. Variation and stability in Schistosoma haematobium egg counts. Trans R Soc Trop Med Hyg. 1973;67(4):475-90.
31. Woolhouse ME, Hasibeder G, Chandiwana SK. On estimating the basic reproduction number for Schistosoma haematobium. Trop Med Int Health. 1996;1(4):456-63.
32. Truscott JE, Turner HC, Farrell SH, Anderson RM. Soil Transmitted Helminths: mathematical models of transmission, the impact of mass drug administration and transmission elimination criteria. In: Anderson RM, Basanez MG, editors. Mathematical Models for Neglected Tropical Diseases: Essential Tools for Control and Elimination, vol. Volume B. 2015.
33. Pediatric praziquantel consortium [http://www.pediatricpraziquantelconsortium.org/]
34. Chan MS, Guyatt HL, Bundy DA, Booth M, Fulford AJ, Medley GF. The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect. 1995;115(2):325-44.
35. Chan MS, Anderson RM, Medley GF, Bundy DA. Dynamic aspects of morbidity and acquired immunity in schistosomiasis control. Acta Trop. 1996;62(2):105-17.
36. Mitchell KM, Mutapi F, Savill NJ, Woolhouse ME. Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci U S A. 2012;109(33):13347-52.
37. Crombie JA, Anderson RM. Population dynamics of Schistosoma mansoni in mice repeatedly exposed to infection. Nature. 1985;315(6019):491-3.
38. Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian RT, et al. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis. 2010;201(7):1105-12.
39. Cheever AW. A quantitative post-mortem study of Schistosomiasis mansoni in man. Am J Trop Med Hyg. 1968;17(1):38-64.
40. Bradley M, Chandiwana SK, Bundy DA, Medley GF. The epidemiology and population biology of Necator americanus infection in a rural community in Zimbabwe. Trans R Soc Trop Med Hyg. 1992;86(1):73-6.
41. Bundy DA, Thompson DE, Cooper ES, Golden MH, Anderson RM. Population dynamics and chemotherapeutic control of Trichuris trichiura infection of children in Jamaica and St. Lucia. Trans R Soc Trop Med Hyg. 1985;79(6):759-64.
42. Elkins DB, Haswell-Elkins M, Anderson RM. The epidemiology and control of intestinal helminths in the Pulicat Lake region of Southern India. I. Study design and pre- and post-treatment observations on Ascaris lumbricoides infection. Trans R Soc Trop Med Hyg. 1986;80(5):774-92.
43. Anderson RM, Truscott JE, Pullan RL, Brooker SJ, Hollingsworth TD. How effective is school-based deworming for the community-wide control of soil-transmitted helminths? PLoS Negl Trop Dis. 2013;7(2), e2027.
44. Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8(11), e3286.
45. de Vlas SJ, Nagelkerke NJ, Habbema JD, van Oortmarssen GJ. Statistical models for estimating prevalence and incidence of parasitic diseases. Stat Methods Med Res. 1993;2(1):3-21.